ResMed to launch onelseeptest by Ectosense
onelseeptest will help millions effectively and accurately diagnose sleep apnea
ResMed, a global leader in digital health, is now distributing the onesleeptest by Ectosense in India to help patients and physicians diagnose millions of Indians who suffer from undiagnosed sleep apnea.
onesleeptest by Ectosense is a disposable, multi-night use test based on peripheral arterial tonometry technology with a built-in NightOwl sensor (driven by Photoplethysmography-PPG technology) to measure key indicators such as heart rate, oxygen desaturation and body movements to determine the sleep quality. The onesleeptest device accurately tracks and delivers results by a certified sleep specialist within three to five working days, making it an ideal solution to test sleep quality from the comfort and safety of your home during the pandemic.
ResMed is launching a three-part “onesleeptest” service in conjunction with World Sleep Day (March 19), includes the home sleep test, along with sleep scoring by a leading sleep physician in India and sleep coach consultancy to support patients’ journey from diagnosis to therapy.
“Home sleep tests are reliable, comfortable and are even recommended by the American Society of Sleep Medicine,” said Seema Arora, Marketing Manager, Asia & LatAm – ANZ, ResMed. “Over one-third of the Indian population suffers from sleeping disorders, and the worst part is, many don’t know they have it and therefore don’t reach out for help. We believe home sleep tests are essential to helping diagnose more people who suffer from sleep apnea, especially at a time when social distancing and contactless diagnosis is encouraged. Therefore, onesleeptest is the ideal solution.”